The long‐term effects of anti‐TNF‐α agents on patients with chronic viral hepatitis C and B infections

Publisher： John Wiley & Sons Inc

E-ISSN： 1756-185x|18|1|40-45

ISSN： 1756-1841

Source： INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol.18, Iss.1, 2015-01, pp. : 40-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review article: long‐term safety of oral anti‐viral treatment for chronic hepatitis B

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 730-737

John Wiley & Sons Inc

Access to resources Recommend Favorite

Monoclonal gammopathy of undetermined significance (MGUS) in patients with psoriasis may be associated with long‐term treatment with efalizumab, but not with anti‐TNF‐α treatments or ustekinumab

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 3, 2015-03 ,pp. : 609-611

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Effects of Interferon-Based Therapy for Chronic Hepatitis C

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 16-23

Karger

Access to resources Recommend Favorite

The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long‐term clinical outcome in chronic hepatitis B patients

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 438-447

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection

By  

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 40-46

John Wiley & Sons Inc

Access to resources Recommend Favorite